In vitro and animal studies of sodium thiosulfate as a potential chemoprotectant against carboplatin-induced ototoxicity

Cancer Research

Volumn 56, Issue 4, 1996, Pages 706-709

  Neuwelt, Edward A ^a,b,c   Brummett, Robert E ^a   Remsen, Laura G ^a   Kroll, Robert A ^a   Pagel, Michael A ^c   McCormick, Christopher I ^c   Guitjens, Sydney ^a   Muldoon, Leslie L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; MANNITOL; SODIUM THIOSULFATE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CAROTID ARTERY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; GUINEA PIG; HAIR CELL; HUMAN; HUMAN CELL; INTRAARTERIAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG SMALL CELL CANCER; NEUROTOXICITY; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ACOUSTIC STIMULATION; ANIMALS; BLOOD-BRAIN BARRIER; CARBOPLATIN; CARCINOMA, SMALL CELL; CELL LINE; CELL SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FUROSEMIDE; GUINEA PIGS; HAIR CELLS, OUTER; HUMANS; LUNG NEOPLASMS; MEMBRANE POTENTIALS; RATS; THIOSULFATES; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0030063767     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Williams, P C , Henner, W. D , Roman-Goldstein, S , Dahlborg, S. A., Brummett, R. E., Tableman, M., Dana, B. W., and Neuwelt, E. A. Toxicity and efficacy of carboplatin and etoposide in conjunction with blood-brain barrier modification in the treatment of intracranial neoplasms Neurosurgery, 37: 1-12, 1995
2. Neuwelt, E. A , Williams, P. C., Mickey, B. E , Prenkel, E. P., and Henner, W. D. Therapeutic dilemma of disseminated CNS germinoma and the potential of increased platinum-based chemotherapy delivery with osmotic blood-brain barrier disruption. Pediat. Neurosurg., 21. 16-22, 1994.
3. Kennedy, I. C. S., Fitzharris, B. M., Colls, B. M., and Atkinson, C. H. Carboplatin is ototoxic. Cancer Chemother. Pharmacol., 26: 232-234, 1990.
4. Dorr, R. T. Chemoprotectants for cancer chemotherapy. Semin. Oncol., 18 (Suppl. 2): 48-58, 1991.
5. Dedon, P C , and Borch, R. F. Characterization of the reactions of platinum antitumor agents with biological and nonbiological sulfur-containing nucleophiles. Biochem. Pharmacol., 36: 1955-1964, 1988.
6. Elferink, F., Van der Vijgh, W. J. F., Klein, I., and Pinedo, H. M. Interaction of cisplatin and carboplatin with sodium thiosulfate: reaction rates and protein binding. Clin. Chem., 32: 641-645, 1988.
7. Abe, R., Akiyoshi, T., Tsuji, H., and Baba, T. Protection of antiproliferative effect of cis-diamminedichloroplatinum (II) by sodium thiosulfate. Cancer Chemother. Pharmacol., 18: 98-100, 1986.
8. Iwamato, Y., Kawano, T., Uozumi, J., Aoki, K , and Baba, T "Two-route chemotherapy" using high-dose ip cisplatin and iv sodium thiosulfate, its antidote, for peritoneally disseminated cancer in mice Cancer Treat. Rep., 68: 1367-1373, 1984.
9. Goel, R., Cleary, S. M., Horton, C , Kirmani, S , Abramson, I., Kelly, C., and Howell, S. B. Effect of sodium thiosulfate on the pharmacokinetics and toxicity of cisplatin. J Natl Cancer Inst., 81: 1552-1560, 1989.
10. Howell, S. B., Pfeifle, C. L , Wung, W. E., Olshen, R. A., Lucas, W. E., Yon, J. L., and Green, M. i.p. cisplatin with systemic thiosulfate protection Ann. Intern. Med., 97: 845-851, 1982.
11. Pfeifle, C. E., Howell, S. B., Felthouse, R. D , Woliver, T. B. S., Andrews, P. A., Markman, M., and Murphy, M. P. High-dose cisplatin with sodium thiosulfate protection. J. Clin. Oncol , 3: 237-244, 1985.
12. Pollay, M., and Kaplan, R. J. The movement of sulfate and thiosulfate into in vivo choroid plexus. J. Neurobiol., 2. 221-230, 1971.
13. Neuwelt, E. A., and Barnett, P. A. Blood-brain barrier disruption in the treatment of brain tumors: animal studies. In: E. A. Neuwelt (ed.), Implications of the Blood-Brain Barrier and Its Manipulation. Vol. 2: Clinical Aspects, pp. 107-193. New York: Plenum Publishing Corp., 1989.
14. Ivankovich, A. D., Braverman, B , Stephens, T. S., Shulman, M., and Heyman, H. J. Sodium thiosulfate disposition in humans: relation to sodium nitroprusside toxicity. Anesthesiology, 58: 11-17, 1983.
15. Brummett, R E., Himes, D L., Saine, B., and Vervon, J A. A comparative study of the ototoxicity of tobramycin and gentamicin. Arch. Otolaryngol., 96: 505-512, 1992.
16. Neuwelt, E. A., and Kroll, R. A Osmotic blood-brain barrier modification: increasing delivery of diagnostic and therapeutic agents to the brain. In: T R. Flanagan, D. F Emerich, and S. R Winn (eds.), Methods in Neuroscience - Providing Pharmacological Access to the Brain: Alternative Approaches, pp. 52-67. Orlando: Academic Press, 1994.
17. Baskin, S. I., Horowitz, A. M., and Nealley, E. W. The antidotal action of sodium nitrite and sodium thiosulfate against cyanide poisoning. J. Clin. Pharmacol., 32: 368-375, 1992.
18. Inoue, M., Shimizu, C., Shimizu, H., and Tanizawa, O. Neutralizing effect of sodium thiosulfate on antitumor efficacy of cisplatin for human carcinoma xenografts in nude mice. Gynecol. Oncol., 40 34-37, 1991